Progenics Pharmaceuticals, Inc. Q1 Loss Smaller Than Expected, Cuts Jobs
Reuters -- Progenics Pharmaceuticals Inc posted a quarterly loss that was significantly narrower than market estimates, helped by a strong rise in revenue and lower research and development expenses, and said it cut 10 percent of workforce to streamline operations.